Kintara Therapeutics Inc

NASDAQ:KTRA  
0.29
-0.01 (-2.36%)
Products

Kintara Therapeutics Granted Fast Track Designation From The FDA For Val-083 For Newly-Diagnosed Glioblastoma

Published: 06/15/2022 13:15 GMT
Kintara Therapeutics Inc (KTRA) - Kintara Therapeutics Granted Fast Track Designation From the FDA for Val-083 for Newly-diagnosed Glioblastoma.